BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20190101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20191027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20211031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200707
DTEND;VALUE=DATE:20200710
DTSTAMP:20260515T093624
CREATED:20200520T091348Z
LAST-MODIFIED:20200520T091348Z
UID:25596-1594080000-1594339199@www.pharmajournalist.com
SUMMARY:Onco Cell Therapy Summit
DESCRIPTION:Onco Cell Therapy Summit (OCTS)\, formerly the CAR-T Congress\, is the leading digital event revolutionizing patient outcomes in cancer therapies. \nThis virtual summit\, taking place June 7 – 9\, spans across 3 half days\, bringing you opportunities to share novel research\, manufacturing techniques and regulatory best practice through virtual panel discussion\, traditional presentations\, polls and round tables\, all from the comfort of your own home. Each session at OCTS 2020 is dedicated to encouraging knowledge sharing and translating novel data assets and IP into commercially viable oncological therapies. \n \nOCTS is a 4-track event and whilst bringing together the key decision makers for CAR-T therapies\, it also focuses on ground breaking science that is driving the surge of interest in harnessing alternative cell therapies in cancer treatments. \nWith 2 of our tracks comprised of research on CAR-T and alternative cell therapies\, the other pillar in rolling out these therapies is increasing the affordability of the treatments. The other two tracks will delve into best practice in commercialization and manufacturing of immuno-oncological cell therapies. \nEach day includes plenty of opportunities to network and there’s multiple panel discussions to also take a deep dive into the key challenges in major topics to R&D\, manufacturing and commercialization. \nThis is one must attend virtual event in the cell therapy field.
URL:https://www.pharmajournalist.com/event/onco-cell-therapy-summit/
LOCATION:Virtual\, EDT Timezone
ORGANIZER;CN="Kisaco Research":MAILTO:events@kisacoresearch.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200709
DTEND;VALUE=DATE:20200710
DTSTAMP:20260515T093624
CREATED:20200619T121040Z
LAST-MODIFIED:20200619T121040Z
UID:25993-1594252800-1594339199@www.pharmajournalist.com
SUMMARY:Direct to Patient and Virtual Clinical Trials – Digital Experience
DESCRIPTION:With COVID-19 creating worldwide disruption in clinical trials and companies looking for innovative approaches to keep trials going\, we at Arena International are delighted to announce the launch of our Direct to Patient and Virtual Clinical Trials Digital Experience. \n \nThis one-day online event will bring together top-class speakers from around the world to discuss themes including remote monitoring\, temperature control in direct-to-patient shipments\, regulations and compliance\, and how to engage patients throughout a virtual trial. \nAlongside listening to presenters in our auditorium\, attendees will have the opportunity to visit our virtual exhibition hall\, chat in our networking lounge\, and set up 1:1 business meetings. \nThis event will be a crucial platform for clinical trials professionals to learn about how to adapt to direct-to-patient and virtual trials in a COVID and post-COVID world\, making it an unmissable event in your calendar.
URL:https://www.pharmajournalist.com/event/direct-to-patient-and-virtual-clinical-trials-digital-experience/
LOCATION:Virtual Event
ORGANIZER;CN="Arena International":MAILTO:Kadin.luong@arena-international.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200715
DTEND;VALUE=DATE:20200716
DTSTAMP:20260515T093624
CREATED:20200624T102414Z
LAST-MODIFIED:20200624T102414Z
UID:26017-1594771200-1594857599@www.pharmajournalist.com
SUMMARY:Clinical Operations In Oncology Trials
DESCRIPTION:To keep pace with the health needs of the growing number of young and old afflicted with cancer globally\, clinical development in oncology is one of the fastest growing areas within the Pharma industry. At this unique virtual event\, attendees will get to learn strategies to better manage communication and relationships between trial sponsors and CROs\, learn ways to create patient-centric trials for higher enrolment rates including addressing the need for more diverse recruitment and much more. Key presenters on the line-up consist of C-level and director-level executives from the likes of Tufts Medical School\, Beat AML\, Pfizer and Agios Pharmaceutical.\nURL: https://arena-international.com/oncologyvirtual/
URL:https://www.pharmajournalist.com/event/clinical-operations-in-oncology-trials/
LOCATION:Vitual Event
ORGANIZER;CN="Arena International":MAILTO:alex.fearn@arena-international.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20200715T090000
DTEND;TZID=Europe/Paris:20200715T181500
DTSTAMP:20260515T093624
CREATED:20200313T110619Z
LAST-MODIFIED:20200529T113416Z
UID:24619-1594803600-1594836900@www.pharmajournalist.com
SUMMARY:Gene Therapy for Neurological Disorders Europe
DESCRIPTION:Gene Therapy for Neurological Disorders Europe is dedicated to solving the translational drug development challenges encountered in the development of gene therapies for neurological disorders. \n \nIndustry pioneers from the leading pharma and biotech companies including Avexis\, uniQure\, and Biogen will share how to improve the translatability of small and large animal models\, develop innovative delivery approaches to guarantee delivery of vector and understand the realities of immunogenicity challenges in the CNS. \nJoin this definitive\, niche digital conference to accelerate the development of your gene therapy pipeline and address the significant unmet need in neurological indications.
URL:https://www.pharmajournalist.com/event/gene-therapy-for-neurological-disorders-europe/
LOCATION:MA
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200716
DTEND;VALUE=DATE:20200717
DTSTAMP:20260515T093624
CREATED:20200611T142323Z
LAST-MODIFIED:20200611T142735Z
UID:25854-1594857600-1594943999@www.pharmajournalist.com
SUMMARY:Prefilled Syringe Elastomer Components - High-quality Solutions for Sensitive Molecules
DESCRIPTION:Join the experts on this free exclusive webinar on the 16th July 2020 at 2pm BST\, hosted by West Pharmaceutical Services\, Inc. \nAs the industry continues to see significant growth for drug products developed in prefilled syringe systems (PFS)\, there is a trend for pharmaceutical companies to evaluate more complex drug molecules\, such as biologics. \nThis webinar discusses current trends in the market for injectable drug delivery and outlines current challenges for companies developing drug products in a prefillable syringe system. \n \nWebinar Overview \nIncreasing demands on quality\, stringent regulations\, trends towards home care treatments by using innovative device technology\, and the development of specialized\, high-value treatments present challenges to companies looking for unique solutions. \nIn this webinar we will cover new elastomer component leading with innovation excellence developed to address the ever-increasing demands. Discussing the challenges of the pharmaceutical industry driven towards components being essentially free of particulate and meeting customer demand for consistency by assuring dimensional stability. \nFor more information on the webinar and to register your free place\, please visit: www.pfs-elastomer-components-webinar.com/mp
URL:https://www.pharmajournalist.com/event/prefilled-syringe-elastomer-components-high-quality-solutions-for-sensitive-molecules/
LOCATION:Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200716
DTEND;VALUE=DATE:20200717
DTSTAMP:20260515T093624
CREATED:20200624T102919Z
LAST-MODIFIED:20200624T102919Z
UID:26023-1594857600-1594943999@www.pharmajournalist.com
SUMMARY:Medical Device Trials
DESCRIPTION:At our first Medical Device Trials virtual event our aim is to support trial sponsors and solution providers internationally to ensure trials are delivered on time\, partnerships are improved and innovations are showcased\, discussing\, deliberating and debating the latest operational and technological challenges with regards to clinical trial in medical devices. Hear talks from Bassil Akra\, Faouzi Kallel from Edwards Lifesciences and many other industry leaders and disrupters!\nURL: https://arena-international.com/ctmd/
URL:https://www.pharmajournalist.com/event/medical-device-trials/
LOCATION:Virtual Event
ORGANIZER;CN="Arena International":MAILTO:alex.fearn@arena-international.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200716
DTEND;VALUE=DATE:20200717
DTSTAMP:20260515T093624
CREATED:20200707T121728Z
LAST-MODIFIED:20200707T122000Z
UID:26229-1594857600-1594943999@www.pharmajournalist.com
SUMMARY:EXCLUSIVE FREE WEBINAR ON Prefilled Syringe Elastomer Components High-quality Solutions for Sensitive Molecules
DESCRIPTION:Join the experts at this free exclusive webinar on the 16th July 2020 at 2pm BST\, hosted by West Pharmaceutical Services\, Inc.We have had over 90 registrations so far\, joining us from:Abbvie\, Aptar\, Aptar Pharma\, BI Pharma GmbH & Co. KG\, BioQ Pharma Inc\, Datwyler\, DEKRA\, Hikma Pharmaceuticals\, j8 Process Consulting Taiwan\, Janssen\, Kansai Plascon\, Lazard\, Lilly\, Nemera\, Novartis\, Ohio State University\, Pfizer Inc\, Regeneron\, Roche\, Sanofi\, Sanofi Pasteur\, Schott\, SCHOTT France\, Sio2 Materials Science\, Softeq\, Sumitomo Rubber North America\, Sun pharma research center\, TUV Italia srl\, TUV Italy\, Vetter Pharma-Fertigung GmbH & Co. KG\, Weiss-Aug Co\, Inc.\, WL Gore\, Zacros (Fujimori Kogyo co. ltd.) and many more!\nWith only less than 2 weeks to go\, if you haven’t already registered your FREE place book your virtual seat here today!Can’t make the date/time? Register your place at the above link and we will send you the webinar\, post event.  \nWebinar OverviewIncreasing demands on quality\, stringent regulations\, trends towards home care treatments by using innovative device technology\, and the development of specialized\, high-value treatments present challenges to companies looking for unique solutions.In this webinar we will cover new elastomer component leading with innovation excellence developed to address the ever-increasing demands. Additionally\, we discuss the challenges of the pharmaceutical industry driven towards components being essentially free of particulate and meeting customer demand for consistency by assuring dimensional stability.Expert Webinar Hosts from West Pharmaceutical Services\, Inc.Christa Jansen-Otten\,Product Management\, Prefilled Systems & DeliveryWhitney Winters\,Senior Director\, Strategic Marketing and container SystemsFind out more information on the webinar hosts here. \nFor more information on the webinar and to register your free place\,\nplease visit: www.pfs-elastomer-components-webinar.com
URL:https://www.pharmajournalist.com/event/exclusive-free-webinar-on-prefilled-syringe-elastomer-components-high-quality-solutions-for-sensitive-molecules/
LOCATION:Webinar
ORGANIZER;CN="SMi Group":MAILTO:hsidhu@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200722
DTEND;VALUE=DATE:20200723
DTSTAMP:20260515T093624
CREATED:20200302T091243Z
LAST-MODIFIED:20200514T082403Z
UID:24438-1595376000-1595462399@www.pharmajournalist.com
SUMMARY:Innate Immune Stimulating Therapies Summit – Running Digitally for 2020
DESCRIPTION:Safely Harnessing Novel Targets of the Innate Immune System for Enhanced Anti-Tumor Effects \nThe inaugural Innate Immune Stimulating Therapies Summit is focused on achieving safe and effective clinical and commercial translation of STING and TLR therapies. \n \nJoin the leaders in the field\, from key biotech\, large pharma\, and academia\, to discuss how to optimize the administration of innate immune stimulating therapies from IT delivery through to antibody conjugated approaches. \nIf you are looking to make long lasting connections with industry leaders and take part in discussions about the lessons learned on the journey to translating safe and effective innate immune stimulating therapies for patients in need\, then this is the meeting for you. Join our online community of industry experts here: https://ter.li/52s56v. Earlybird and group discounts apply. Book early to secure the best possible rate on your ticket.
URL:https://www.pharmajournalist.com/event/innate-immune-stimulating-therapies-summit/
LOCATION:Online\, MA
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200722
DTEND;VALUE=DATE:20200723
DTSTAMP:20260515T093624
CREATED:20200612T152417Z
LAST-MODIFIED:20200612T155249Z
UID:25917-1595376000-1595462399@www.pharmajournalist.com
SUMMARY:RNAi-Based Therapeutics Summit – Running Digitally for 2020
DESCRIPTION:Digitally Join the RNAi-Based Therapeutics Community \nWe are excited to announce that the RNAi-Based Therapeutics Summit has gone virtual! \nAs the first multi-disciplinary discussion for large pharma\, biotech and academic leaders specifically dedicated to the RNAi therapeutics\, the industry will be coming together on Wednesday\, July 22 to successfully optimize cell-specific strategies\, overcome pharmacology and delivery challenges to accelerate translation and clinical development of RNAi therapeutics in the liver\, CNS and beyond. \nCheck out the official event guide for full speaker and session details. \nJoin this virtual summit to meet those pioneering the field and to hear from 19+ world-class experts that are sharing their latest perspectives: \n\nDong-ki Lee\, Founder & Chief Executive Officer\, OliX Pharmaceuticals\nElena Feinstein\, Chief Scientific Officer\, Quark Pharmaceuticals\nKaryn O’Neil\, Chief Scientific Officer\, Aro Biotherapeutics\nBrooke Rock\, Director\, Amgen\nSharmistha Ghosh\, Associate Director\, Arrowhead Pharmaceuticals\nBaisong Mei\, Senior Global Project Head\, Sanofi\nDavid Corey\, Professor\, UT Southwestern\n\nDownload the updated program to see the full list. \nWith several clinical candidates emerging and momentum building in the field\, join the RNAi-Based Therapeutics Summit – your comprehensive\, industry-focused virtual meeting dedicated to bringing together senior biopharmaceutical leaders from discovery\, translation\, and clinical development functions to advance pioneering RNAi platforms that improve patient outcomes. Secure your ticket now. \nLooking forward to seeing you at our virtual meeting!
URL:https://www.pharmajournalist.com/event/rnai-based-therapeutics-summit-running-digitally-for-2020/
LOCATION:Virtual Event
ORGANIZER;CN="Hansonwade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR